Top 20 Trending Stocks On WallStreetBets As Of Friday, July 16, 2021 (Via Swaggy Stocks)
Today, 9:22 PM
Data from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment
ContextLogic (WISH)
Nvidia (NVDA)
SoFi Technologies (SOFI)
Virgin Galactic (SPCE)
Clover Health Investments (CLOV)
Corsair Gaming
Stocks That Hit 52-Week Highs On Friday
Today, 9:22 PM
During Friday's morning trading, 90 companies set new 52-week highs.
Vaccine Stocks Climb After Moderna Added To S&P 500, With BioNTech Also Up
Today, 9:22 PM
The first week of earnings season wraps up with major indices closely tracking the bond market in Wall Street’s version of “follow the leader.” Earnings absolutely matter, but right now the Fed’s policies are maybe a bigger influence. In the short-term the Fed is still the girl everyone wants to dance with.
Benzinga Pro’s Top 5 Stocks To Watch For Friday, Jul. 16, 2021: MRNA, SREV, LIZI, YVR, GLG
Today, 9:22 PM
Today's 5 Stock Ideas
Moderna (MRNA) - Shares were up 7% ahead of the open Friday following Thursday evening news the stock will be added to the S&P 500.
ServiceSource (SREV) - A stock
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen’s Anemia Drug, Corvus Shelves COVID Study
Today, 9:22 PM
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 15)
Why Moderna Shares Are Rallying Today
Today, 9:22 PM
Shares of COVID-19 vaccine company Moderna, Inc. (NASDAQ: MRNA), which ended Thursday's session with a market cap of $104.3 billion by virtue of a 5.28% rally, are seeing follow-through buying interest Friday.
22 Stocks Moving in Friday’s Pre-Market Session
Today, 9:22 PM
Gainers
Aehr Test Systems (NASDAQ: AEHR) shares rose 25.3% to $3.52 in pre-market trading after the company reported better-than-expected Q4 results and issued strong FY22 sales guidance.
Moderna Is Now More Valued Than Gilead, GlaxoSmithKline: How Long Did COVID-19 Vaccine Maker Take To Hit $100B?
Today, 9:22 PM
Moderna Inc (NASDAQ: MRNA) stock is on a roll, with its vaccine-induced momentum spilling over into 2021.